← Назад к работе
Работы, на которые ссылается эта работа
Работ: 257
Работа: Eurasian guidelines for the prevention and treatment of cardiovascular diseases in patients with obesity (2022)
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Bertram Pitt, Faı̈ez Zannad, Willem J. Remme +5
Статья1999Цитирований: 3ABIAchieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials
Michael Böhm, Helmut Schumacher, Koon Teo +10
Обзорная статья2017Цитирований: 3ABIAngiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes
Hussam Abuissa, Philip G. Jones, Steven P. Marso +1
Обзорная статья2005Цитирований: 2ABIIs There an Obesity Paradox After Percutaneous Coronary Intervention in the Contemporary Era?
T. Lancefield, David Clark, Nick Andrianopoulos +9
Статья2010Цитирований: 2ABIEffect of uncomplicated obesity on QT interval in young men
Erol Arslan, Ömer Yiğiner, İrfan Yavaşoğlu +3
Статья2010Цитирований: 2ABIObesity and the Risk of Incident, Post-Operative, and Post-Ablation Atrial Fibrillation
Christopher X. Wong, Thomas Sullivan, Michelle T. Sun +9
Статья2015Цитирований: 2ABIEffect of Valsartan on the Incidence of Diabetes and Cardiovascular Events
John J McMurray, John J.V. McMurray, Steven M Haffner +51
Статья2010Цитирований: 2ABIEffect of Obesity and Overweight on Left Ventricular Diastolic Function
C Allison Russo, Zhezhen Jin, Shunichi Homma +4
Статья2011Цитирований: 2ABIPatients with Metabolic Syndrome Have Prolonged Corrected QT Interval (QTc)
Weiju Li, Yongyi Bai, Kai Sun +7
Статья2009Цитирований: 2ABI